Global TIL Therapy Market is driven by Personalized Treatment Demand
Tumor-infiltrating lymphocyte (TIL) therapy involves the extraction, expansion, and reinfusion of a patient’s own immune cells to target cancerous tumors. This advanced immunotherapy product offers distinct advantages over conventional treatments, including high specificity, reduced systemic toxicity, and the ability to overcome tumor heterogeneity. Clinical studies demonstrate that TIL...
0 Comments 0 Shares 151 Views 0 Reviews